feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Undeclared Ingredients > Golean DETOX Capsules

Recall: Golean DETOX Capsules

email
email

On 2019-02-25, the FDA announced that Golean Detox USA is conducting a recall on DETOX Capsules due to possible undeclared sibutramine, phenolphthalein. The recalled products were sold under the brand name(s) Golean during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 5 drugs recalls due to potential undeclared ingredients, including indian herb, male enhancement nutritional supplement and more. Additionally, there have been 15 drug and medical device recalls due to other health hazards as well as 83 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These


Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Golean Detox USA
Website: http://www.goleandetoxus.com/
Phone: 704-537-2595

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information



Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: DETOX Capsules

Brand Name(s): Golean

Reason for Recall: Undeclared Sibutramine and Phenolphthalein

Official Recall Date: 2019-02-25


Advertisement

Additional information provided by the FDA.gov:

Golean Detox USA Issues Voluntary Nationwide Recall of Golean DETOX Capsules Due to Presence of Undeclared Sibutramine and Phenolphthalein

For Immediate Release
February 25, 2019

Contact
Consumers
Golean Detox USA
goleandetox085@gmail.com
704-537-2595

Announcement

Golean Detox USA, Charlotte, NC is voluntarily recalling all lots within expiry of Golean DETOX capsules to the consumer level. FDA analysis has found Golean DETOX capsules to be tainted with undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the U.S. market due to safety concerns. Phenolphthalein was once an ingredient used in over-the-counter laxatives, but because of concerns of carcinogenicity is not currently approved for marketing in the United States. The presence of sibutramine and phenolphthalein in Golean DETOX renders it an unapproved drug for which safety and efficacy has not been established and, therefore, subject to recall.

Risk Statement: Products containing sibutramine pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Health risks of ingesting phenolphthalein could include potentially serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use. These products may also interact in life threatening ways with other medications a consumer may be taking. To date, Golean Detox USA has not received any reports of adverse events related to this recall.

This tainted product is marketed as a dietary supplement for weight loss and is packaged in 14 packets containing 2 capsules per packet, a total of 28 capsules per box, UPC 8 938510 909013. Golean DETOX capsules were sold Nationwide in the USA to customers on Facebook at www.goleandetoxus.com.

Golean Detox USA is notifying its customers that have the Golean DETOX capsules and is arranging for return of all recalled products. Consumers that have Golean DETOX capsules should stop use and return the product.

Consumers with questions regarding this recall can contact Golean Detox USA by phone 704-537-2595 or goleandetox085@gmail.com Monday - Thursday, EST, 4:00 pm to 6:00 pm.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm1 Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm2 or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


More information may be available at FDA.gov
Advertisement


Latest Safety Recalls

Select image for details, including additional styles.

 

Advertisement

Comments

Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top



Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Consumers
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
Developers
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Researchers
Product Recall Statistics
About
Company
Contact
Press
Blog

Social
Facebook
Twitter